SCHEMBL9574694

SCHEMBL9574694

O=C(NCCO)Oc1ccc(NS(=O)(=O)c2ccccc2-c2ccccc2)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ SLC22A12 Q96S37 1/20 0.42
▸ EDNRA P25101 3/20 0.40
▸ FEN1 P39748 5/20 0.40
▸ HTT P42858 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ ALOX5AP P20292 4/20 0.38
▸ CASP1 P29466 2/20 0.37
▸ EDNRB P24530 2/20 0.37
▸ NAMPT P43490 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9574709 0.84 FEN1 (0.40) EDNRAFEN1ALOX5APCASP1EDNRB
SCHEMBL7869169 0.84 GABRA5 (0.44) —
SCHEMBL8868651 0.83 HIF1A (0.46) EDNRAFEN1ALOX5APEDNRBNAMPT
SCHEMBL9574909 0.78 HTT (0.44) MEN1KMT2AHTTALDH1A1LMNA
SCHEMBL7867915 0.75 ALKBH2 (0.40) FEN1ALOX5AP
SCHEMBL8868209 0.74 EGLN1 (0.45) MEN1KMT2ASLC22A12EDNRACASP1
SCHEMBL9574772 0.73 ALDH1A1 (0.41) MEN1KMT2ATSHRALDH1A1LMNA
SCHEMBL8869198 0.73 POLB (0.47) MEN1KMT2AEDNRAFEN1ALDH1A1
SCHEMBL7869455 0.71 P4HTM (0.57) SMN1; SMN2BCL2L1MCL1
SCHEMBL8747682 0.70 EDNRA (0.47) EDNRAFEN1ALOX5APCASP1EDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 — — EP disclosed
Send feedback